Lite Strategy LITS
NASDAQ LITS
$1.06 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Operating Leases (2020 - 2024)

Lite Strategy (LITS) posted Operating Leases of $10.6 million for Q1 2024, down 3.61% on a QoQ basis from $11.0 million in Q4 2023, and down 9.02% year-over-year from $11.7 million in Q2 2023.

Analysis

Lite Strategy (LITS) Operating Leases (2020 - 2024) Analysis & Trends

Lite Strategy has reported Operating Leases for 5 years, with the latest figure at $10.6 million in Q1 2024.

  • On a quarterly basis, Operating Leases fell 9.02% year-over-year to $10.6 million in Q1 2024; TTM through Mar 2024 was $10.6 million, a 9.02% decrease from a year earlier, with the FY2023 full-year figure at $11.3 million, up 28.83% from the prior year.
  • Operating Leases was $10.6 million for Q1 2024 at Lite Strategy, down from $11.0 million in the prior quarter.
  • The five-year high for Operating Leases was $12.4 million in Q3 2022, with the low at $6.9 million in Q4 2021.
  • Average Operating Leases over 5 years is $9.7 million, with a median of $9.2 million recorded in 2022.
  • The sharpest annual moves came in 2021 and 2022: Operating Leases retreated 21.34% in 2021, then surged 75.45% in 2022.
  • Over 5 years, Operating Leases stood at $8.7 million in 2020, then fell by 21.34% to $6.9 million in 2021, then surged by 75.45% to $12.0 million in 2022, then declined by 8.44% to $11.0 million in 2023, then slipped by 3.61% to $10.6 million in 2024.
  • The last three Operating Leases figures came in at $10.6 million (Q1 2024), $11.0 million (Q4 2023), and $11.3 million (Q3 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Lite Strategy 38.03 Mn 30.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 10.62 Mn
Dec 31, 2023 11.01 Mn
Sep 30, 2023 11.33 Mn
Jun 30, 2023 11.30 Mn
Mar 31, 2023 11.67 Mn
Dec 31, 2022 12.03 Mn
Sep 30, 2022 12.38 Mn
Jun 30, 2022 8.77 Mn
Mar 31, 2022 9.21 Mn
Dec 31, 2021 6.86 Mn
Sep 30, 2021 7.12 Mn
Jun 30, 2021 7.37 Mn
Mar 31, 2021 8.51 Mn
Dec 31, 2020 8.72 Mn
Sep 30, 2020 8.67 Mn